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Lung surfactant is a mixture of lipids and prot eins which iscritica I
for normal breath ing by lining the air-water interface to reduc e the surface
tension. Lung surfactant prot ein B (SP-B) is the only esse ntia l prote in
compon ent of lung surfactant complex due to the lethalit y of any SP-B
deficiency. It is thought that SP-B functions by enhan cing lipid
rearrangements at various phases of the breathin g cycle . However,thehigh-
resoluti on structure and mechan ism ofSP-B are not yet under stood. In the
first part of this research , SP-B and a 7- residue deletion mutant of SP-B
were produc ed recombinantlyand partia llycharacterized. In the second part
of this research, circular dichroi sm, so lution and solid-state nuclear
magnetic resonance (NMR) methods were used to assess the structure of
two SP-B-b ased peptid es, Super-Mini-B and N-terminal insertion sequence
(SP-B I_7) . Super-Mini-B is composed of the N-terminal 7-residue inserti on
sequence and the N-and C-terminal helices ofSP-B. Intere stin gly, it was
observed that Super-Mini-B produc es greater lipid membrane pertu rbation
than the pept ide which lacks the N-terminal inserti on sequence (i.e. Mini-
B). Comparing the results of structura l studies on Min i-B, SP-BI_7 and
Super-Mini-B helps unveil the contribution of the 7-residue insert ion
sequence to the function of SP-B.
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The respiratory system functions as the supplier of oxyge n to the
blood. Gas diffusion happens at the alveolar level in very close proximityt o
lung capillaries. There are about 300 million alveoli in the lungs providing a
total surface area of about 140 m1 (Guyton and Hall, 2006). The alveolar
walls are lined by alveolar epithelial cells which are in direct contactwith
respiratory gases (Figure I).
Figure 1. A schematic diagram of the human respiratory system. Lung
surfactant, a lipid-protein complex, lines the inner surface of alveoli and
reduccsth e surfacet ension atthe air-waterintcrfacet o facilitatebreathin g.
The constant exposure to environmental gases and particl es
requires the presence of aO.2 mm thick water layer coating the inner surface
of the alveoli. This layer prevents the dehydration (Bastacky et al. 1995).
When water forms a surface with air, water molecules strongly attract each
other; the forces of attraction between water molecules are strongerthant he
interface . The surface tens ion forces air out causing the alveoli to collapse
and consequently disrupts respiration (Guyto n and Hall, 2006) . The natural
remedy to decrease the surface tension and maintain intlatio n is the presence
of lung surfactant, a complex mixture of lipids and proteins (Whitsett et al.,
2010). Lung surfactant complex decreases the surface tension by formation
of the surface active films at the alveolar level and transfer ofsurface active
materia ls between the air-water interface and hypophases (Serrano et al.,
2006).
Deficiency or inactivation of lung surfactant either by premature
birth,gene mutation or lung injury leads to severe respiratorydisorders. The
pathophysiological effect of' surfactant defic iency was first diagno sed in
premature infant s with neonatal respiratory distress syndrome (NRDS ).
Lung surfactant does not normally begin to be secreted into the alveoliuntil
the sixth or seventh months of pregnancy , in some cases , even later than
that. Thus many premature babies have little or no surfactant in the alveoli,
which gives rise to avery high tendency for lung collapse (Griese, 1999).
NRDS affects about 1 percent of newborn infants ; it is the leading cause of
death in prematurely born babies (Hallman et aI., 200 1). The respiratory
disorder resulting from the damage and dysfunction of surfactant during
injuri es or sepsis is ca lled acute respirator y distress syndrome (ARDS).
ARDS has a high rate of fatalit y, between 36% to 52% (Seeger et al., 1993).
Mutations in the genes encoding surfactant protein B and surfactant
protein C (SFTP13and SFTP C, respecti vely)can lead to acute respirator y
failure and inte rst itial lung diseases. Respirat ory failur e in mature newbom s
due to mutat ion in SP-B and SP-C encoding genes is extremely rare but has
been observed repeatedly as an inher ited cause of severe respi ratory
dysfuncti on (Nogee et al., 2000).
Surfa ctant replacement therapy has had a proven role in the
treatment of NRDS and may have a role in the treatment of patient s with
ARDS . However, efforts to use rep lacement surfactant to treat ARD S have
not been success ful thus far; deacti vation of the replacement surfactant
reduces the efticiencyofendoge nous surfactant therapy in these patients
(Gunther eta l., 1999; Stevensand Sinkin,2 007).
Surfactant based drugs can cont ain both the phosph olipid and
protein content. Synthetic surfactants differ remarkabl y from natu ral
surfactants in thei r protein compo sition (Marraro, 2004). The origin al
commercially avai lable surfactant, (Ex osurf; Glaxo Wellcom e), does not
contain any surfactant proteins. Clinical trials have shown artifi cial
surfactants are much more effecti ve if they include surfactant proteins as
compared to protein- free prep aration s (Lewis and Veldhui zen , 2003).
Natural surfactants, derived from animal lungs by organic extraction,
contain surfactant proteins and are much more effective in lowering the
surface tension (Stevens and Sinkin,2007).
There are two type of epithelial coveri ng the alveolar surface; type
I and type II cells. Type I cells form the structure of an alveolar wall while
all lung surfactant compone nts are synthesized by type II alveolarepithelial
cells. After secretion to the alveolar space, lung surfactant phospho lipidscan
form distinct physical structures from monolayersto multilayers, ineluding
tubular myelin and lamellar bodies, as well as vesicular, protein-lipid
structures. Formation of these structures is mainly affecte d by the
stoichiometr y of lipids and surfactant proteins, and physical forces
genera ted during respiration (Whitsett, et aI., 20 10). Although the
composition of lung surfactant can vary from one species to another, lung
surfactant is composed of around 80% phospholipids, 5- 10% neutral lipids
- mainly cholesterol- , and 8- 10% proteins making up 5-6 % of total
surfactant mass (Goerke, eta l., 1998).
The lipid fractio n of mammalian surfactants (by mass) is composed
of around 80% phosphatidylcholine (PC), about half of which isthe
disaturated form dipalmitoylphosphatidylcholine (DPPC) (Veldhuizen, et
aI., 1998). Different levels of tluidity during the respiration cyele requ ire a
balance between the presence of saturated and unsaturated lipids. The most
remarka ble difference ofs urfactant composition inhumans in compariso nto
other mammalian membranes is the unusual high content of DPPC and
anionic phospholipids, mostlyphosphatidylglycerol (PG) (Wustneck, et al.,
2005) . DPPCis ararephospholip id species in othertissuesbut evolut ionary
has been chosen. DPPC's saturated chains pack to a high density at the air-
water interface at physiological temperature and provide a significant
reduction in surface tension at the end of expiration (Hawcoa et a1.,1 981).
In mice and humans at 37°C, the physiological temperature, pure
phospholipids have a slow rate of film formation and weak surfactant
activity. Appropriate rate of film formation, stability during respiration
cycle and re-spreading capacities are dependent on the presence of the
surfactant proteins (WhitseU and Weaver, 2002 ; Halliday, 1996).
Surfactant proteins designated surfactant protein A (SP-A), SP-il ,
SP-C, and surfactant protein D (SP-D), play critical roles in variousaspects
of surfactant structure, function, and metabolism (Perez-Gil, 2008). In
general they are divided in two main groups; the hydrophilic surfactant
proteins SP-A and SP-D, and the hydrophobic surfactant proteins SP-Band
SP-C. SP-A is the most abundant protein componen t ofsurfactant(Sueishi
and Benson, 1981) which is associate d with surfactant phospholip ids
(Schurch et al., 1992; Bi et al., 2001). SP-Dis found in avery small amount
in the lavage and does not associate with lipid containing structures
(Haagsman and Diemela, 200 1). The structures of SP-A and SP-D allow
them to bind to diverse ligands underlying their role in the innate immune
system at the lung surface (Crouch and Wright, 200 1). SP-B and SP-C
compose 1-1. 5% of total surfactant mass. These hydroph obic prot eins
interact with the lipids in lung surfactant (Shi ffer et al ., 1993; Taneva and
Keough,1 994).
SP-I3is theonly lungsurfactantprotein whose deficiency is lethaI
(Clark et al., 1995; Tokiedaeta l., 1997). SP-I3ex ists in different classesof
vertebrates includin g fish (1ungfish),amphibians, reptilesand mammals; in
human the encodi ng gene is located on chromoso me 2. It belon gs to the
family of sapos in-like prot eins, which possess a specia l fold of around 80
amin o acids containing amphip athic alpha-he lices and three co nserve d
disu1phide bridges in conserve d positions (Munford et aI., 1995). All
sapos in-like proteins have activities related to interaction with phosp ho lipid
memb ranes (Patthy, 1991).
The mature SP-I3 isolated from lung lavages is a highl y
hydrophobic peptide with 79 amino acids, with - 8 kDa molecular mass; the
functiona l form is a hom odimer. It possesses three cova lent intram olecular
disulph idebondsperm onomer and an additi onaldisulphid ebond stabili zing
the dimer (Serrano et al.,2006) (Figure 2) . lti s synthesized as aprecursor
(38 1 amino acids) followed by proteolytic clea vage ofN- and Csterminal
propept ides in severa l different steps that resu lt in the mature sequence
(Braschetal.,2003;Uenoeta l.,2004).
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Figure 2. Schematic diagram of mature SP-B and SP-B homodimer.
Disulfide bonds connecting the predicted helices are shown byd ashed lines.
The fourth disulfide bond (red dashed line) stabilizes the dimer. The amino
acid sequence and expected helical regions (boxes) are shown, cysteine
residues are highlighted in grey.
The synthesized precursor SP-B is transported from the
endoplasmic reticulum to the Goigi apparatus and then to multivesicular
bodies where it is packed into lamellar bodies. Proteolytic processing of SP-
B occurs in type II pneumo cytes during the exocytic pathwa y of surfactant.
The active SP- B peptide is stored with SP-C and surfactant phospholipid s
in lamellar bodies (Voorhout et al., 1992; Korimilli eta 1.,2000 ).
Severa l mechanisms have been suggested to underlie SP-B's
function including enhancing the interfacia l adsorption of phospholipids
from the hypophase to the air-wa ter interface (Cruzetal., 2000 ; Schram
and Hall, 2004), stabilizing compressed films at the alveolar surface(Krolet
al., 2000), facilitating the re-spread of the surfacta nt mater ial during
expansion and providing lowest surface tensio n during respiration cycle. It
has been proposed that SP-B functions as a link fro m bilayers (hypophases)
to the monolayer (air-water interphase) and back (Taneva and Keough,
1994; Zaltashe t al.,2000) (Figure 3).
... ...
... ...
Figure 3. A model representing the role ofSP-B during compression (a.
pointing in arrows) and expansion (a. pointing out arrows) of breathing
cyc le.S P-B mediates bilayer-b ilayera nd bilayer- monolayertransitions.
Previo us works have show n that SP-B fragments can retain simi lar
act ivitie s to the full-length SP-B. The N-terminal half of SP-B consists of
amino acids 1-37, and has a high numbe r of hydrophobi c and ca tionic
residues that provi des lipid-int eraction properties. C-terminal basedpeptid es
also showed in vitro and in vivo surfactant activities (Kang et al., 1996;
Baatz et al., 199 1; Ryan ct al. , 2005). Enhancement of oxyge nation and lung
compliance, dynam ic re-spreadin g in animal model s, membr ane
permeab ilization and liposome lysis have been reported for N- or C-termi nal
helical fragments of SP-B (Revak et al. , 1991 ;Walther etal.,2002)(Figure
4).
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Figure 4. Schematic diagram ofSP-B peptides synthesized based on the
prcdictedhel ical segments of SP- B. SP-B NTERMand SP-BCTERMaredesigned
based on the N- and C-terminal helices of SP-B respect ively. Super-Min i-B
and Mini-B are N- and C-terminal containing peptides. The disulfide bonds
connecting the helices are shown by dashed lines.
A recent in vivo study (Waltheret al., 2010) assessed biological
activities of a group of SP-B pcptides; Mini-B. Super-Mini-B and N-
terminal fragment of SI'-B (SP-B,_s). Mini-B is a 34-residue peptide that
consists of the N- and C-terminal predicted helical regionsofS P-B. Super-
Mini-B is a 41-residue peptide with two internal disulfide bonds that
contains theN-terminaI7-residue insertion sequence and the predicted N-
and C-terminal helices of SP-B. These regions are connected via a loop as
well as two disulfide bonds (Waring et al., 2005). Super-Mini-B can be
considered as a modified Mini-B since the only difference is the presenceof
the insertion sequence (SP-B,_7) (Tab le I).
Table! . Amino acid sequences of SP-B, Mini-B and Super-Mini-B.
Disulfide bonds are formed between cysteine residues highlighted by gray
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In this study (Walther, etal. 20 10), lung lavaged rats were treated
by artificia l surfactants composed of lipids alone and lipids plus SP-B,
Mini-B, Super-Mini-B and N-terminal fragment of SP-B (SP-BI .s). The
study included the meas urement of arterial oxygenation and lung dynamic
compliance in lung lavaged rats with ARDS and controls. The treatment
with lipids alone did not improve the oxygen content in blood. Lipids + SP-
BI•8 improved it only slightly more than lipids alone. Lipids + Mini-S
produced higher oxygenation levels than lipids + SP-B. Lipids + Super-
Mini-B reached the highest value for arterial oxygenation (Figure 5). The
results suggest that the N-terminal insertion sequence (SP-B I•7) , in
combination with the N- and C-terminal helices of SP-B, provides greater
surfactant activity than either the N- and C-terminal helices alone, or full
length SP-B.
Lungdynamiccompliance isrelatedtothevolumeoftheairthat is
exchanged during respiration . Measurement of this value by Walther and
co-workers indicated a similar relative activ ity of the peptides compared to
the oxygenation measurem ents. The only difference was that lipids + Mini-
B had a lower activity than lipids + SP-B (Figure 5). This result indicate s
that the presence of N-terminal insertion sequence (SP-B 1_, ) may be
important for lung expansion-compression. It also supports the possibilityof
a differ ent mechanism of function of SP-B for oxygenation compared to
lung dynamics.
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Figure 5. Arterial oxygenation and dynamic comp liance in rats subjectedto
removal of lung surfactant by in vivo lavage. Exogenously surfactant
replacement was administered by synthetic surfactants preparedfrom lipids
only and lipids plus native SP-B or SP-B peptides. Synthe tic lipids + 1.5
mol % Super-Mini-B , Mini-B, or SP-BI_8 • synthetic lipids +1.5% porcine
SP-B and synthetic lipids alone as a control. Arterial partial pressure of
oxyge n (Pa0 2) and dynamic lung compliance (mUkg/ cm H20; calculated
by dividing tidal volumelkg body weight by changes in airway pressure) are
shown asa function of time after surfactant administration. The plots are
self-prepared using the published data of Ref. Waltheret al. 2010 .
The knowledge ofa structure ofa protein provides information on
its molecular mechanism of function . The exac t three-dimensional structu re
of SP-B is still unknown . Structure of some SP-B peptides have been
determined by solution nuclear magnetic resonance (NMR) experime nts; the
N-terminal peptide (SP-BI I.25) (Kurutz and Lee, 2002), and the C-tenn inal
peptide (SP-B6J •78) (Booth, et aI., 2004) (Figure 6). The high resolution
structure of Mini-B has also been determined (Sarkeret aI., 2007) (Figure
6). In order to define the importance of the N-tennina l 7 residues of SP-B
(SP-B I_7) , results of structural studies on Mini-B and Super-Mini-B.
particularly NMR experiments, were compare d.
Figure6.The high-reso lutionst ructuresofth ree terminalfragmentsofSP-B
determ ined by solution NMR . The fragments are SP-B NTERM (SP-B II-25) in
methanol (PDB lD IKMR) (Kurutz and Lee, 2002), SP-BCTERM (SP-B6J.7S)
in sodium dodecyl sulfate (SDS) micelles (PDB ID 1RGJ ) (Booth et al.,
2004), reduced Mini-B (SP-BS-25+6J.78) in hexafluoroisopropanol (HFIP)
(PDB ID 2JOU) and oxidized Mini-B in SDS micelles (PDB ID 2DWF)
(Sarke r et al., 2007) . The disulfide bonds are not shown.
NMR is commonl y employed in studying three dimensional
structures of proteins. One of the advantages ofNMR spectroscopy is that
data can be acquired in solution. Studying the structure of proteins in
solution with the possibility of adj usting conditions (such as tempe rature,
pH and salt concentration) allow us to closely mimie physiological
conditions and study in vivo functions of proteins (WUthrich, 1986).
NMR is a property that makes particular nuclei in a magnetic field
absorb energy from the applied electromagnetic pulse and radiate this
energy back out. These nuclei are called NMR active nuclei or y, spin
nuclei. The energy radiated back out from each nucleus has a
specific resonance frequency depending on the strength of the magnetic
field and the environment surrounding the nucleus (Poehapsky and
Pochapsky, 2007). In proteins purified from natural sources there is only
one V, spin nucleus, IH.
The axes in NMR speetra are frequency, normally represented as
chemical shift. The chemical shift describes the dependency of the radiated
energy level of a magnetic nucleus on the electronic and chemica l
environmen t surrounding that particular nucleus. Solution-state NMR
experiments provideinforrnation about the structure of a protein based on
two types of corre lations between nuclei; corre lations between nuclei with
- 3 cova lent bonds of each other (from total correlation spectrosco py
(TOCSY) experiments), and interactions between nuclei that are close to
each other through the space conformation, but not through the chemica l
bond (from nuclear overhauser effect spectrosco py (NOE SY) experiments)
(Cavanagh et aI., 1996).
One of the limitations of solution NMR is the size issue. Larger
molecules have slower tumbling rates and shorter NMR signal relaxation
times . This reduces the sensitivity of received signals and result to weak
peaks. Also more complexity will introduce to a spectrum by large size
molecules because there are more NMR-active nuclei and more interactions
among them (Yu, 1999}.It is hard to get information of the structure from
broad and low intensity peaks. The limitation of solution-state NMR in
studying hydrophobic proteins such as SP-B is that, this class of proteins
cannot be brought into a sutlic ientlyconcentrated solution due to their
highly hydrophobic nature (Laws et aI., 2002) . Detergent or lipid micelles
can be used to mimic the lipid environment to solubilize these proteins. A
micelle is an aggregate ofa mphiphilic molecules, in a polar solvent( mostly
water}. These amphiphilic molecules contain a hydrophilic head group and
one long or two short acy l chains. When the concentration of these
molecules in water is greater than a certain value, known as the critical
micellar concentration (CMC), spherical structures called micelles are
formed which the hydrophilic head groups are exposed to watermolecules
and burying the acy l chains inside. Nevertheless solubilisation of
hydrophobic proteins by lipid containing solutions is not helpfu I enough for
NMR studies since the proteins in comple x with lipids tumble very slowly
and don't give rise to detectable peaks in solution NMR spectra (Sander s
andSonnichsen, 2006).
Solid- state NMR works based on the resonance of NMR-acti ve
nuclei in the magnetic field . In this technique , interaction s between nuclei
are orientation dependent and take place in media with no or little mobil ity.
It is an alternative technique to give information about the protein structure.
However it does not provide high resolut ion structural data in comparisonto
solution-state. Solid-state NMR is also a valuable tool to study local
dynamics, kinetics and thermodynamics of protein-lipid interactions in
protein-m embrane systems (Laws et aI., 2002). Since SP-B is a membran e
associated protein, studying SP-B peptides in lipid bilayers by solid-state
NMR provides precious information about SP-B/lipid interactions.
In spite of SP-B's importance, attempt s at recombinantexpression
of the full-length protein and chemical synthesis of a near-full proteinhave
not succeeded yet, main ly due to its high degree of hydrophobicityand the
prescnceofthree intrachain disulfide bonds. However, fragmentsofSP-B
retain much of the function of the full length protein (Kanget al., 1996;
Baatz et al.,1 991; Ryan et al., 2005),m aking them helpful to understand the
mechanism of the full length protein. Additionally, peptides are of interes t
as they pose substantial advantages over full length proteins to useas
therapeutics, e.g. for NRDS or ARDS.
The main objec tives of this work are to produce full/near full length
SP-B suitable for NMR studies and to understand the role of the N-terminal
7residuesofSP-B. SP-B based peptides encompass similar activi ties to the
full length protein, this fact raise the hypothesis that particularstructural
features of SP-B are responsi ble for particular activities of SP-B. In this
research , structural studies on SP-B peptides; Super-Mini-B and N-termin al
insertion sequence ofSP-B (SP-B I _7) . The research was performe d using
solution and solid-state NMR spectrosco py in order to characterize the
structural changes and membrane interactio n properties induced by the by
presence ofN-terminal insertion sequence in the context ofSP-B peptides.
Moreover, recombinant expression ofSP-B in an attempt to produce the
full-length protein and opt imizing expression conditions were investigated.
In this work also production and expressionofa nove l near full-IengthSP-B
peptide ; N-terminal deleted SP-B (Nd-SP-B) were examined. The overall
resultof thisresearchprovides a strongfoundationforfuture studies on the
produc tion, conformation and interactions of full-length SP-B.
2.1. S equence identifi cation of SP-B encoded plasmid
The plasmid containing full-length SP-B gene was designed and
synthesized by members of the Jesus Perez-Gil lab at Universidad
Complutense (Spain). Starting with this plasmid, it was transformed into
DI15a E. coli cells. The plasmid was amplified in these cells, the cells were
harvested and the DNA isolated using the extraction and purification
procedures of QIAprep® Miniprep kit (QIAGEN Inc. Mississauga, ON).
Bacterial cells were harvested from a 2 ml cell culture by micro
centrifugation. The pellet wassubjec ted to the alkaline-SDS lysis procedure.
The solution added to a micro column fi lled with silica and equilibrated
with a high salt concentration. DNA adsorbed onto the column and
contaminants were removed by a simple wash step. The bound DNA was
eluted in water or Tris-EDTA buffer. The purified DNA was sequenced by
the Genomics and Proetomics (GaP) Facility, (Memorial University).
2.2. Transformati on of tile plasmid to tile expression cell line
After confirmation of sequences, I ftl (0. 1 ng/ul ) of the purified
DNA was added to a 50 ftl aliquot of competent C43(DE3) cells. The
transformation reaction was incubated on ice for 30 minute s. Theheat shock
was applied for 45 seconds at 42°C and then the reaction was placed on ice
for 2 minutes. 500 fll of lysogeny broth (LB) medium was added to the
transform ation reaction and incubated at 37°C for 1 hour. The LB medium
consisted 01'10 g/L tryptone, 5 g/L yeast extract, 10 g/L NaCl, pH 7. After
incubation, the transformati on reaction was plated on LB- ampicillin ( 100
flg/m1)aga r plates and the plates were incubatedat3 7°C for 16 hours. Later
in my work to optimize the cell growth, I have used terrific broth (TB)
media which is a richer than LB. TB medium is consisted of 12 gil tryptone,
24 gil yeast extract, 9.4 gil potassium phosphate (dibasic), 2 gil potassium
phosphate (monobasic). The final pH was adj usted at 7.
2.3. Recombinant expression of'full length surfactant protein B
An isolated colony on the transform ed plate was selected and placed
in 10 ml LB-ampicillin ( 100 ug/ml), The mixture was incubated overnight
at 37°C. The overnight culture was added to 750 ml LB-a mpicillin broth.
Cells were grown at 30°C until the 001000 reached 0.7, and then isoprop yl p-
O-I-thi ogalactopyranoside (IPTG) (I mM) was added to induce expression
ofS I'-B. Alier 4 hours incubation . the cells were harvested by cent rifugation
at 4000 g for 10 min. The pellet was resuspended in a minimi zed amount of
resuspension buffer (10 mM Tris HCI pH 7.9, I mM ethylenediaminetetra
acetic acid (EOTA), 0.01 M phcnylmcthane sulfonyltluoridc or
phcnylmethylsulfonyl fluoride (PMSF)) and kept in -20°C freezer until
In order to break the cell membranes, pellets were subjected to
French press at room temperature, sonication while the sample was kept on
ice. The French press container and the sonication probe were coo led down
by ice before usage. After the cell rupture, Iris buffered saline (TBS) 1%
lauroyl sarcosine detergent (TBS= 50 mM Tris, 150 mM NaCI, pH 7.6)
centrifuged at 18,000 g forlOmin. The fusionprotein waspurified fromthe
supernatant via immobilized metal affi nity chromatography. The coba lt
contai ning resin was used to make a His-Trap column (TALON Metal
Affinit y Resin, Clontech Laboratories,lnc. Mountain View, CA, USA) . The
column was equilibrated with TBS 1% lauroyl sarcosine bulle r. The
supernatant was loaded onto the coba lt column and the column was washed
with TBS, 1% lauroyl sarcos ine, 75 mM imidazole. The protein was eluted
from the colum n by the elution buffer contai ning TBS, 1% lauroyl sarcosine
and 500 mM imidazo le. The eluted protein was dialyzed aga inst water to
remove imidazo le, buffer and detergent. After dialysis, the solution was
2.4. Production & recomb inant exp ression of tile Nsterminal deleted SP-B
Site-direc ted mutagenesis was applied on the full-length SP-B
containing plasmid. Stratagene 's QuikChange® Site-Directed Mutagenesis
kit (Agi lent Technologies Canada Inc. Mississauga, ON) was used to delete
the N-terminal fragment of SP-B. The forward and reverse primers were
designed persona lly based on the full sequence of the plasmid and
considering the desired deletion mutation. Both of the mutagenic primers
contained the mutation and anneal to the same sequence on opposite strands
of the plasmid (Table 2). The encoding sequence of seven N-terminal
residues of SP-B (FPIPLPY) was absen t in mutagenic primers. The
synthes ized mutagenic primers were ordered and purchased from Sigma-
Aldrich Co. (St. Louis MO). 5 f1lof to- reaction buffer was mixed with 2 f1l
(5-50 ng) dsDNA template (the purified plasmid DNA of the bacteria
before the mutation), 2 f1l (125 ng) forward primer, 2 ul (125 ng)reverse
primer and I f1l deoxyri bonucleotide triphosphate (dNTP) mix. Double
distilled water was added to bring the volume to 50 f11. Then I f1l of Pfu
DNA polymerase (2.5 U/ul) was added to reaction mixture.
Polymerase chain reaction (PCR) was to used to amplify the
mutation reaction. The PCR reaction was as follows: a pre-denaturation
step, 30 seconds heat treatment at 95°C. The reaction was followed by 18
cyc les of denaturation, 30 seconds at 95°C, annealing for I minute at 55°C
and extension for 20 minutes at 68°C. The secon d part of the PCR reaction
was repeated for 18 cycles . After completion of the reaction, I f11 of the Dpn
I restriction enzyme (10 Ulfll) was added to the amplifi cation produc t and
incubated at 37°C for 1 hour to digest the parental (unmutated) DNA. Dpn I
is an endonuclease, specifi c for methylated and hemime thylated DNA. It is
used to digest the parental DNA. DNA isolated from almost all E. coli
strains is methylated and therefor e susceptible to Dpn I digestion . The
sequencing of mutation product s confirmed the efficiency of Dpn l. The
mutated product was transformed into C43(DE3) E. coli cells. The same
procedure s,asdescribedin2.1 to 2.3, were applied to prepare a sample for
DNA sequencing and expression.
Table 2. The sequences of forward and reverse primers designed for sitedirected
deletion mutation on the N-termin al ofSP-B.
Primers The sequence
Forward 5'-GTTCC ACGG GGCCCATGCTGGCTCTGCA GG
Primer
Reverse 5'-CCTGC AG AGCC AGCATGGGCCCCGTGGAAC
Primer
2.5. Ident ification of the expressed peptide
The recombinant ly expressed peptides were identified using
western blotting by immunoblotting of anti-histidine antibody. The histidine
tag was inserted at the N-terminal of the desired peptide , thepurpose was to
facilitate the purification process through metal affinitychromatographyand
also the anti-histidine antibody was used to detect the expression of the
desired peptide. Since the desired peptide is a novel construct using a
synthesized antibody is not convenienl. Forwestemblotting, first the eluted
protein from column chromatogram (described in 2.3) was loaded on a
SDS-I'AGE, sodium dodecyl sulfate polyacrylamid e gel electrophore sis,
gel. The SDS-I'AGE gel consists of both stacking gel and separating gel.
Gels were solidified in a gel caster. To prepare a 12% SDS-I'AG E gel, first
the 10mi separating gel was poured and polymer ized. The separat ing gelis
made of 4 ml 30% acrylamide mix (acrylamide 29.2% + 0.8% N,N'-
methylenebi sacrylamide), 6 ml 0.75 M Tris pH 8.8, 0.2 % SDS, 100 fllIO %
ammonium persulfate (AI'S ) and 20 fll tetram ethylethylcnediamine
(TEMED). The 5 ml stacking gel was made of650 fl130% acrylamide mix,
4.35 ml 0.13 M Tris pH 6.8, 0.12% SDS, 100 ul 10% AI'S and 10 ul
TEMED. Chemicals were purchased from Sigma-Aldrich Co., St. Louis MO
and Fisher Scientific Co. Ottawa, ON. After the separating gel was
thoroughly solidified,the stacking gel solutionwas addedtothecaster and a
plastic comb was inserted to form wells. Then the gel was placed in a
running chamber filled with I x SDS running buffer (25 mM Tris pH 8.3,
250 mM glycine, 0.1% SDS). The protein sample was dissolved in sample
buffer (65 mM Tris-HCl pH 6.8, 1.3% SDS, 13% glycerol, 1% p-
mercaptoethanol, 0.02% sodium azide and 0.02% bromophenol blue),
boiled for I minute and loaded into one of the wells. The electrophoresis at
180 V was completed when the sample buffer dye (bromophenol blue)
reached to the bottom of the gel.
Electrophoretic transfer of the protein from the gel to a
polyvinylidcne fluoride (PVDF) membrane (Millipore Corporation, MA,
USA) was carried out by electrophoresis at 60 V for 120 minutes. The
membrane was then kept for I hour at room temperature in a solution of 5%
non-fat milk in TTBS; TBS (20 mM Tris, 0.5 M NaCI, pH 7.6) and 0.05%
Tween-20. The membrane was then incubated with a primary antibody
against the histidine tag, monoclonal Mouse IgG I, at room temperature for
2 hours, and then the antibody solution was washed from membran e in
TIBS for several times. The membrane was incubated with the secondary
antibody (polyclonal Goat Anti-Mouse IgG Alkaline Phosphatase
conjugated) for 1 hour at room temperature followed by severa l wash steps.
The dilution time for the primary antibody (anti-h istidine)was l:5 000 ( 1 fd
in 5000 ul) and the secondary antibody is 1:3000. Antibodies were
purchased from Sigma-A ldrich Co., St. Louis, MO. To visualize the bound
antibodies, BCIPINBT color reaction was employed. BCIP (5-bromo-4-
chloro-3-indolyl-phosphate) in conj unction with NBT (nitro blue
tetrazolium ) are used as chromogenic substrates for the colorimetric
detection of alkaline phosphatase activity. BCIP as a color generator and
NBT for signal enhancement, they are idea l for immunoblotting while
alkaline phosphatase is conj ugated to the seco ndary antibody. 5ml of
alkaline phosphatase buffer ( lOOmM Tris-HCl [pH 9.0], 150mM NaC!,
ImM MgCI2), 75 mg/ml NBT in 70 % dimethylformalmamide (DMF) and
50 mg/ml BCIP in 100% DMF were mixed, the solution were applied to the
PVDF membrane that was treated with the primary antibody in the previous
step. NBT and BCIP were bought from Sigma-Aldrich Co.
2.6. Chemical synthesis and purification of Nstermlnal fragment of SP-B
N-terminal insertion sequence of SP-B (FPIPLPY) was produced
by solid-phase synthesis using 9-fluorenylmethyloxycarbonyl (Fmoc)
chemistry. Amino acids were weighed out in 5x excess and placed into a CS
Bio peptide synthesizer (model CS336X, CS Bio Company Inc, Menlo Park,
CAl using 0.43 g of a 0.47 mmol/g Rink amide resin (CS Bio Company Inc,
Menlo Park, CAl . Dissolut ion and de-blocking of amino acids were
facilitated using a 0.4 M I-hydroxy-benzotriazole dissolved in
dimethylformamide (DMF), and a 20% peperidine/DMF solution (Sigma-
Aldrich Co., St. Louis, MO). The resin was washed with DMF. After
completion of synthesis, the resin containing synthesized SP-BI_7 was
transferred to a 10 ml syringe equipped with a filter, and washed with
methanol. Then the resin was air dried for 30 minutes followed by vacuum
drying tor 60 minutes. The peptide was cleaved from the resin by a cocktail
consistingof9 ml trifluoroaceticacid( TFA), O.25 ml l,2 -Ethanedithiol, O.1
ml thioanisole (Sigma-Aldrich Co.), and 0.25 ml distilled water. The peptide
was precipitated from the solution by addition of 50 ml of-20°C diethyl
ether. The precipitate was pelleted down by centrifugation at 4°C, 4,000
rpm,5 min. The precipitant was collected and allowed to air dry ove rnight.
Purification procedure was carried out by using high-pressure
liquid chromatography (HPLC) (Varian ProStar HPLC, Varian Inc., St.
Laurent, QC). The lIPL C was equipped with a reverse-phase DYNAMAX
C8 preparatory column (Varian lnc., St. Laurent, Qc) , and a
spectrophotomete r operating at a wave length of 215 nm. The peptid e was
eluted using an acetonitrile gradient (80/20% HPLC grade water/acetonitrile
- 0/100% acetonitr ile; Sigma-Aldrich Co). The mass and sequence of the
peptide were confirmed through matrix assis ted laser desorption ionization -
time of flight mass spectrometry (MA LDI-TOF MS) by Genomics and
Proteom ics (GaP) facility (Memorial University).
2.7. Solution nuclear magnetic resonance (NMR)
The structure of Super-Mini-B and SP-BI _7 were assesse d by
solution-state nuclear magnetic resonance (NMR). The peptides were
investiga ted in an organic solvent (HFIP) and a membrane mimicking
environment (detergent containing solution). I mM Super-Mini-B or 2 mM
SP-BI_7 were dissolved in 40% HFIP(hexafluoroisopropanol), 50% H20 and
10% 0 20 with 0.4 mM 4,4- dimethyl-4-silapentane- l -sulfonic acid (OSS) .
For detergent containing solution, I mM Super-Mini-B were dissolved in
90% H20 , 10% 0 20 , 0.2 mM DSS, and ISO mM dcuterated SOS (Sodium
dodecyl sulfate). Values were the same for 2 mM SP-B I_7 SOS sample
except the peptide was dissolved in 300 mM deuterated SOS. Oeuterated
SOS, OSS and 0 20 were purchased from Cambridge Isotope Laboratories,
Inc. (Andover, MA). For all experiments, OSS was used to obtain the proton
reference signal at 0 ppm and water-ga te water suppression was used with a
3-9-19 pulse. All two dimensional experiments used a recycledelay ofl
second. One dimensional (10) and two-dimensional (20) NOESY , TOCSY
and diffusion ordered spectrosco py (OOSY) expe riments were carried out
using a TXI probe on a Bruker Avance 600 MHz at Centre for Chemical
Analysis, Research and Training (C-CART) (Memoria l University).
For I D I H NMR, 32 scans were recorded. A mixing time of 200 ms
was used with 160 scans for the 20 NOESY . For the 20 TOCS Y, a D1PSI2
sequence was used, and the mixing time was 80 ms, with 128 scans .
Acquisition of spectra was performed using TopSpin (Bruker, Milton, ON) .
Spectra were processed using iNMR (http:// .inmr.net) and
analyzed using SPARKY (Goddard and Kneller, 2005) . For NMR structural
studies, each peak needs to be assig ned asa specific nucleus in the molecule
under investigation. Resonance assignments also have to be sequence-
specific, i.e., each peak must be assigned to a nucleus or correlation of
nuclei in a particular amino acid in the protein sequence . IH peaks were
assigned to a chemical group type on the basis of their chemical shifts.
Amide protons (HN) resonate between 10.0 and 7.0 ppm, the backbone a-
protons (Ha or HA) resonate between 6.0 and 3.5 ppm, the aliphatic side-
chain protons resonate between 3.5 and 1.0 ppm and the methyl protons
resonate at chemica l shifts less than 1.5 ppm (Cavanagh eta l., 1996).
The diffusion experiments were performed on 150 mM SOS in H20
and 0 20 with I mM Super-Mini-B at pH 5 and 30 °C, with the same sample
used for other solution NMR experime nts. The pulse sequence for diffusion
measurement used stimulated echo with bipolar gradient pulses, followed by
3-9-19 pulse for water suppressio n. OOSY spectra were collected in 32
steps, attenuating signals to about 5% of the initial value by increasing the
gradient strength from 2% to 95% of the maximum amplitude, for a constant
diffusion time of 100 msand an optimized gradient pulse length 01'4 ms.
The spectra were processed using iNMR and the ditTusion constants
calculated using the "DOSY" package in DOSYTooIBox08 (Nilsso n, 2009) .
16-doxyl-stearic acid (16-DSA) was added from a 2 mM OSA in
NMR SOS containing butler to Super-Mini-B and SP-B1.7 samp les, the final
concentration of DSA was 0.6 mM. The samples were used for OSA-
TOCS Y experiments. DSA was purchased from Sigma-Aldrich Co., (St.
Louis MO).
2.8. Solid-state nuclear magnetic resonance (NMR)
The oriented lipid/lipid-p rotein sampleswereprepared using Rainey
and Sykes procedure (Rainey and Sykes. 2005). Muscovite mica (grade V-a .
dimension: 75 x 25 x 0.26 mrrr' ), purchased from Structure Probe (West
Chester, PAl, was cut into small pieces to prepare 12 plates with
dimensions of 12.5 mm x 5 mm and thickness of -4 0 urn. Deurterated 1-
palmitoyl-2-0Ieoyl-sn-glycero-3-phosphocholinc, POPC-dl l , and 1-
palmitoyl-2-0Ieoyl-sn-glycero-3-phospho-(I '-rac-glycerol), POPG, were
purchased from Avanti Polar Lipid (Alabaster, AL). For the lipid only
sample, 4 mg of POPC-dl ! and POPG at a ratio of 7:3 were dissolved in a
solvent composed ofC HJOH/CHCll (1:1 by volume). For the lipid-peptide
sample, I mol % (by weight) of Super-Mini-B was added to the lipid-
organic solvent solution. The solution, with a total volume of - 250 ~I , was
spread over mica plates. Theplates weredriedfor - 2h in a fumehood and
then placed in a vacuum chamber overnight. A few microliters of deuterium
depleted water were spread on each plate and the plates were kept in a
hydration chamber with saturated ammonia phosphate solution at 4°C for 3
days. Then the plates were stacked together, wrapped with a plastic film,
and sealed with polystyrene plastic. Samples were stored at 4°C. The 2H
spectra were acquired at a temperature of 296 K on a spectrometer operated
ata resonance frequencyo f6 1A MHz.
2.9. Circular dichroism (CD) spectroscopy
Samples prepared for structural studies by solution NMR
(preparation described in 2.7) were also investigated by circular dichroism
(CD) spectroscopy. The secondary structural characteristics of Super-Mini-
£3, Mini-B and SP-B I _7 were assesse d in aqueous (HFIP containing samples)
and lipid mimickin g environment (SOS samples). The CO spectra were
obtained using a Jasco J-810 spectropolarimeter. Experiments were carried
out at 25°C using 1 mm quartz cuvette. The spectra were acquired as the
resu!tof 4 repeated scans from 260 to 200 nm, using scan intervalsofl nm
and an integration time of 1 s at each wavelength, Secondary structure
content was calculated from the spectra using COPro software
(http://lamar.colstate.edu/-ss reeram/COPro) deve loped by Woody and co-
workers (Sreerama and Woody, 1993). CD values were converted to mean
residue ellipticity (MRE). Basis set 2 of the COPro software was used and
analysis was completed using CONTIN/LL method (Johnson, 1999:
Sreerama andWoody, 2000 ; 2004).
3.1. Detection of expressed recombinan t full length SP-B
The starting point of this study was the plasmid DNA provided by
Jesus Perez-Oil' s research group at Universidad Complutense (Spain) . The
plasmid was designed to contain the full-length SP-B gene fused to
staphylococcus nuclease (SN). SN as a fusion protein is attached to SP-B
through a linker sequence. A recognition site for protease digestion
(thrombin digestion) was provided to separate SP-B from the fusion part.
Six histidine residues were added to the N-terminus ofSN sequence to
facilitate purification of the expressed protein by metal affinity
chromatography.
The plasmid was amplified in D115u E. coli cells in an overnight
cnlture of LB media. The DNA sequencing of multipl e clones confirmed the
expected sequence for the designed plasmid [DNA sequencing-g enomics
and proteomics (Ga P) facility, Memorial University]. The plasmid was then
transformed into the C43(DE3) cell line. This specific strain of E. coli is
genomically modified to provide the optimum over express ion of toxicand
hydrophobic proteins( Dumon-Seignoverte ta l. 2004).
Transformed cells were cultivated in LB media and induced by 1
mM [PTG. After the overnight induction, cells were centrifuged down and
the pellet was collected. 10% Lauryl sarcos ine was added to the pellet
before the cell disruption procedure in order to enhance cell membrane
disruption and to solubilise the hydrophobic expressed protein. Cells were
thcn disruptcd by French press and sonication.
The express ed protein was purified from the cell extract by the
affinity of the histidine tag to a cobalt column. Detection of the purified
protein on aComassie stained gel was not promising because three bands
were detected in the purified sample while we were expecting only one band
(Supplementary material, Figure St. ). In Western blot analysis a single
immunopositive band was observed (Figure 7), as probed by an antibody
specific for the histidine tag (since an antibody against SP-B is not
ava ilable). The apparent molecular mass of the expressed fusion protein was
estimated by compari son to the molecular mass markers run on the same
SDS-PAGE gel used for Western blotting. The expected molecular mass for
SN-SP-B is - 27 kDa while the estimated size of the detected band is
approximately 22 kDa.
Figure 7. Western blot analysis of the cell extract harvested from the
overnight culture of cells encoding SN-SP-B plasmid. a) The band
represents antige n-a ntibody reaction upon applying anti-Histidine antibody.
The histidine tag is located at the N-terminal of SN-SP-B sequence.
While a large diffe rence in apparent molecular weight via SDS-
PAGE is not unexpected for a hydrophobic protein (see Discussion)-
characterization of the expressed construct by an alternative method was
desirable. For this, MALDI-TOF MS was used [genomics and proteomics
(GA P) facility, Memorial University]. The purified sample was digested by
trypsin that cleaves peptide chains at the amino acids lysine or arginine,
except when either is followed by proline. The trypsin digestion is a helpful
step to allow an efficient tandem mass spectroscopy . Tandem (MS/MS)
mass spectrosco py is a technique to use more than one analyzer and so can
be used for the pept ide sequencing. First the mass spectrometer ionization
source (MAL O!) ionizes the sample molecules. The mass analyzer
(TO I' analyzer) separates the ions formed in the ionization source of the
mass spectrometer based on their mass-to-charge (mlz) ratios. In the
tandem-type mass spectrometer, two mass spectrome ters are connected in
tandem. Between the two mass spectrometers is an ion selector for selecting
only a specific ion. For example in TOFTOF mass spectrometers, ions are
separated in the first TOF stage. Just before a specific ion reaches the ion
selector, the selector voltage is turned off. Then, after the ion of interest
passes the ion selector, its voltage is turned on to allow only the ion of
interest to pass. The MS/M S spectrum can provide information about the
amino acid sequence of the peptide of interest.
Results confi rmed the sequence of some fragments from the fusion
protein and SP-B (Figure 8 and Table 3). While the presence of the N-
terminal residues ofSP-B was detected by mass spectroscopy, I was not
able to detect the remaining portionsofSP-B using this method.
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Figure 8. MS/MS spectra ofSN-SP-B sample produced using MALDI-TOF
mass spectroscopy. A) The mass/charge ratios of the fragment
corresponding to histidine tag sequence is labeled. B) Peaks corresponding
to the sequence ofN-terminal fragment ofS P-B are labeled. The amino acid
sequcnces of these detected fragments are shown in Table 3.
Table 3. MS/MS analysis confinned the presence of two fragment s with the
from the SN-SP-B construct (indicated by gray highlighting). Red
represents the SP-B sequence and blue represents the fusion part consisting
of the sequence of histidine tag, SN and the linker. [RG] is the action site of
thrombin. Trypsin potential cleavage sites are underlined.
SN-SP-Bexpectedaminoacid sequence
ATSTKKLHKEPATLIKAIDGDTVKLMYKGQPMTFRLLLVDTPE
ADGKMVNEALVRQGLAKVAYVYKPNNTHEQHLRKSEAQKKEKLNIWSED
CWLCRALIKRIQAMIPKGALA VAVAQ
VCjiVVPL VAGGICQCLAERYSVlLLDTLLGjiMLPQLVCRLVLjiCSM
A.[)ctectcdSequenceofthefusionpart
3.2. Investigating disruption oj protein syn thesis ami proteolysis induced
bystress-activated proteins
The electrophoresis and mass spectroscopy work in the previous
section brought up the possibility that either SP-B may be produced by the
bacteria in a truncated form, or may be proteolyzed during its expression. To
investigate these possibilities, cell cultures were collected I hour, 3 hours, 5
hours and 18 hours (overnight) after induction by !PTG. After the cell
disruption, Western blotting of the cell extract showed bands at the same
molecular mass (-22 kDa) for all time points. Results showed that the
expressed SN-SP-B did not change at different time points after induction
(Figure 9).
Figure 9. Western blot representation of time course collected cultures after
induction. a) I hour;b) 3 hours; c) 5 hours; d) 18 hours (overnight) after
induction. Protein concentration was not equal in samples; the presence and the
size of the band were only investigated.
3.3. Investigating effect of cell disruption techniques 011 the expressed
protein
Another possible explanation for the low molecular weight
observed for the expressed protein was peptide breakage by mechanical
forces during cell disruption. Although sonication usually does not break
cova lent peptide bonds, the possible destructive effect ofFrenchpress and
sonication were investigated (Figure 10). A combination of these techniques
were applied to the cell pellet; two times French press and two times
sonication, one time French press and two times sonication, two times
French press, one time French press, and five times freeze and thaw as a
control. The detected band in western blot analysis was identical in apparent
size under all conditi ons (-22 kDa) confirming that expressed SN-SP-B was
not cleaved by cell disruption forces.
Figure 10. Western blot analysis of 100 ml cell extracts subjec ted to
different cell disruption techniques. a) 2 times French press and 2 times
sonication; b) I time French press and 2 times sonication; c) 2 times French
press; d) I time French press; and e) 5 times freeze and thaw. Protein
concentration was not adj usted in samples; the presence and the sizeof the
band only were investigated . Diffu sion of bands is due to sample
overloading.
3.4. Optimi zing growth conditions
lncreasing the levels of SN-SP-1l expression was important both for
better conlirm ingth e sequence ofth e expressedprotein, as well asfor future
structural studies. Therefore 1 next worked to optimize bacterial growth and
protein expression condit ions. The type of the media and concentration of
lPTG for induction were investigated (Table 4). First, the total protein
concentration was measured for 500 ml cell cultures grown in Til (Terr ific
Broth) and LB media. The cultures were induced by I mM IPTG. The total
protein yield Protein concentration increased significantly in Til which isa
A previous study showed that protein expression can be improved
by decreasing the concentration of lPTG used to induce expression
(Romano, et al. 2009). I exami ned the effect of IPTG concentration on SN-
SP-B expression by the transformed cells. Protein content was measured
after inducing LB cultures by a gradient of lPTG concen trations. Results
showed that up to 0.4 mM IPTG, the total protein concentration is
increas ing. Decreases in protein concentration were evident at higher
concentrations of lPTG. Both 0.4 mM and I mM IPTG were tested in TB
media cultures. Total protein content was significantly higher for cultures
inducted by 0.4 mM lPTG compared to I mM IPTG.
Table 4. Optimizing !PTG concentration to maximize protein express ion.
Total protein concentration of samp les with equal volume, resulting from
cell extrac ts of 500 ml overn ight cultures was measured by the Bradford
assay. LB cultures were induced by four different IPTG concen trat ions. TB
media cultures were induced only by 0.4 mM and I mM [PTG. X means
these concentrations of [PTG in TB were not investigated.
IPTG( mM)
LB(mglml)
TB(mglm l)
3.5. Production of 0 novel S P-B peptide; Nsterminal deleted SP-B peptid e
The diffic ulties in confirming the full sequence of the
recombinantly expressed SN-SP-B by mass spectroscopy are likely related
to the highly hydrophobic nature of SP-B. Parallel studies with fragmentsof
SP-B(seesection3 .9)indicatedtheN-terminaI7 residucsofSP -Bmightbe
particularly problematic. Even if we cou ld confirm the full sequence, we
would face similardifliculties in further structural studies on the sample. ln
order to produce a novel near full-length SP-B peptide without affec ting its
expected helical structure, seven amino acids from N-termina l end of SP-B
were removed by site directed mutagenes is (Figure II ). The resulting gene
had a histidine tag followed by SN (as the fusion protein) and N-tenn inal
deleted SP-B (Nd-S P-B). DNA sequencing of multiple transformed clones
confinned the success of mutation.
MHHHHHHA TSTKKLHK EPATLIKAIDGD TVKLMYKGQPMTFRLLLVDTPE
TKHPKKGV EKYGPEASAFTKKMV ENAKKIEVEFDKGQRTDKYGRGLAYIY
ADGKMVN EAL VRQGLAKVA YVYKPNNTH EQHLRKSEAQKK EKLNIWSED
NADSGLGGGGGLVP[RGjP CWLCRALlKRIQAMIPKGALAVAVAQVCRVVP
LVAGGlCQCLA ERYSVILLDTLLGRMLPQLVCRL VLRCSM
Figure I I. The expec ted amino acid sequence ofN-tenni nal deleted SP-B
peptide. Blue represents the sequence of the fusion protein; staphylococcus
nuclease (SN). Red is the expected sequence forN -tenn inal deleted SP-B (-
7AA) , [RGj is the recognition site of thrombin.
3.6. Identifi cation of expressed recombinant N-terminal deleted SP-B
The mutated plasmid containing SN-Nd-SP-B was transformed into
the C43 E. coli strain. The cell extract from an overnight induced culture
was purified on a cobalt column (Figure 12). Western blot analysis
identifiedtwobands -2Iand22kDawiththe histidine tag.S incebandsare
very close they can be result of the partial reduct ion of dis ulfide bondsin
the protein. The fract ion of protein remai ning withdisullide bonds move
slower through the gel than the reduced fraction of protei n. C43(DE3) are
mutants that allow over-ex pressio n of some globular and membran e proteins
unable to be exp ressed at high-levels in the parent stra in BL2I (DE3).
Cysteines in the E. coli cytoplasm (including C43(D E3)) are act ive ly kept
reduce d by pathways involving thioredoxin redu ctase and glutaredoxin. The
disulfide bond dependent folding of heterologous proteins is improve d in
some strain s (the Origami strains by Novage n) (Sore nsen, H. P. &
Mortensen, K. K., 2005) . In my work the represented bands are from post
ce ll disruption steps . Afte r the rupture, most likely disullide bond forma tion
happens. However the molecular mass for both band s is less than expec ted
for Nd-SN -SP-B (-26 kDa). The sample was purified through cobalt
column and was digested by trypsin for MAL Dl-TOF MS [genom ics and
proteomics (GaP) faci lity, Memo rial Univers ity]. Mass spec troscopy cou ld
detect fragments from SN and the linker part ofSN-Nd-SP-B (Figure 13 and
Tab leS) .
Figure 12. Western blot analysis of the cell extract from an overnight
induced culture encodin g SN-Nd-SP-B . Bands represent antigen -antibody
reaction upon applying anti-Histidine antibody. The histidine tag is located
at the N-terminus of SN-Nd-SP-B. Samples from different stages of protein
extraction were loaded on the gel a) supernatant after cell disrupti on and
solubilisation (1% lauroyl sarcosine) b) 30 III ofS N-Nd-SP-B resulting from
the elution step of cobalt affinity chromatography (applying 200 mM
imidazole) c) 60 III of eluted SN-Nd-SP-B d) flow through after loading the
sample and e) wash after loading the sample (75 mM imidazole). Protein
concentration was not adjusted in samples; the presence andthe sizeof the
band were investigated.
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Figure 13. MS-MS spectra resulting from MALDI-TO F mass spectrosco py of SN-
Nd-SP-I3 trypsin digested sample. A) The mass/charge ratio of a fragment of SN
is labeled. B) Peaks corresponding to the sequence of SN and the linker are
labeled. The amino acid sequences of the detected fragments are shown in Table
Table 5. MS/MS analysis of SN-SP-B trypsin digested sample identified two
fragments with the expect ed sequence (indicated by gray highlighting). No
fragment was detected from Nd-SP-B. Red represents the SP-B sequence and
blue represents the fusion part consisting of the sequence of histidine tag, SN and
the linker. [RG) is the recognition site of thrombin. Trypsin potential cleavage
SN-Nd-SP-B expected amino acid sequence
MHHHHHHATSTKKLHKEPATLIKAIDGDTVKLMYKGQPMTFRLLLVDTPE
KHPKKGVEKYGPEASAFTKKMVENA_
DGKMVNEALVRQGLAKVAYVYKPNNTHEQHLRKSEAQKKEK
AGG ICQCLAERYSVILLDTLLGRMLPQLVCRL VLRCSM
Detected Sequence of th e fusion part
Detected Seq uence of Nd-S P-B
3.7. Production and characterization of Nsterminal insertion sequence
(SP-HpJ
The first 7residuesofSP-B (the insertion sequence) were produced
by chemical synthesis for structural studies . SP-BI_7 was synthesized by
Fmoc chemistry (section 2.6). The peptide was purified by using reverse -
phase HPLC. The HPLC was equipped with a reverse-phase DYNAMAX
C8 preparatory column (Figure 14). The purified peptide was collected for
further studies by mass spectroscopy. The mass and sequence of the peptide
were confirmed through MALDI-TOF MS [Genomics and Proteomics
(GAP) facility, Memorial University].
Figure 14. HPLC spectrum ofS P-BI_7 eluted with an increasing acetonitrile
gradient. Samples were run through a preparatory reverse-phase HPLC
chromatographer equipped with a OYNAMAX C-8 column . The strongest
[highest absorbance in mill i-absorbance units {mAUl at 215 nm] peak {- 19
min) was collected tor sequencing by mass spectroscopy. The strong peak at
the beginning of the spectrum belongs to water.
Circular dichro ism studies were carried out to assess secondary
structural characteristics of SP-B 1•7• CO spectra of 2 mM Super-Mini-B
were recorded at 25°C and pH 5 in aqueous solution with 40% HFIP (plus
50% H20 and 10% 0 20), as well as membrane-mimeti c environment s (90%
~hO, 10% 0 20 , 0.2 mM OSS, and 300 mM deuterated SOS). Efforts to
solubilize the peptide either in 40% HFIP or SOS buffer were not
successful; most of the sample was insoluble and precipitated . Second ary
structural features of the soluble portion were calculated from the CD
spectra using COPro software (http://lamar.col state.edul- ssreeraml COPro )
and CONTIN/LL analysis method (Sreerama and Woody, 1993; 2004). The
results for SP-B I_7 in 40% HFIP and SOS buffer were similar; the curves did
not have the typical pattern tor a helical conformat ion (Figure 15). The
calculated secondary structural content were similar for HFIP and SOS
containing samples; mostly unordered structures (45.8% in HFIP, 46.1% in
SOS) and ~-structures (27.3% in HFIP, 26.7% in SOS) . A very small
portion was detected tor a -helical structures {0.3% and - 1.5% 31O-helixin
40% HFIP and SOS, 31o-helix is a right-handed helical structure), the
I
~ -1000
peptide retain s the same content of 13% polyprol ine II structure in 40%
HFIP and SOS (Table 6).
N-Term Pept ide
- HFIP
- SOS
-20001+90----.-2.--10----.22,-0 -2.--30---,24,-0 --,----,
Figure IS. Far-UV CO spectrum of 2 mM N-terminal SP-B peptide
dissolved in 40% HFIP (plus 50% H20 and 10% 0 20 ) at pH 5 (red) as well
as in the presence of 300 mM SOS NMR buffer containing 90% H20 , 10%
0 20 , 0.2 mM OSS, and 300 mM deuterated SOS (green). All spectra were
taken using a I mm path-length quartz cuvette from 193 nm to 260 nm at
Table 6. Secondar y structural contentof 2 mM SP-B 1•7 in the presence of
300 mM SDS NMR buffer, and 40% HFIP NMR buffer at pH 5 and 25°C.
Structura l content percentages were calculated from CD spectra data using
Woody and co-worker s method (Sreerama and Woody 1993; 2000 ; 2004).
3.8. Solution III/clear magnetic resonance spectroscopy (NMR)
preliminary structural characterization of N-terminal insertion peptide
The structural characteristic s ofSP-B 1•7 were studied by solution
NMR experiment s. The 2D TOCSY and NOESY are the standard
experiment s to identify interactions betwee n spin systems.
2D NMR experiment s with SP-B' .7 in SDS micelles cou ld detect
only a few peaks with low intensitie s. Even though between spin systems
SP-B '.7 is a small peptide , the number of observed peaks was still fewer
than expected . This cou ld be because the peptide forms large aggregated
particles which do not give rise to solution NMR peaks (Figure 16).
As was mentioned in section 2.7, in a NMR spectrum each peak is
associated with a specific magnetic (V, spin) nucleus in the investigated
molecule. In a 2D NMR spectrum, each cross-peak is assoc iated with 2
nuclei. In order to assign the peaks in the NMR spectra of Sl--Bj.-, firstthe
TOCS Y was employed to indicate which peaks were in the same spin
system and hence in the same amino acid residue. The spin systems were
then assigned to an amino acid type based on comparison to the random coil
values (Wuthrich, 1986). The majority of the peaks in the TOCS Y spectrum
were assigned within ±O.7 ppm off the expected proton resonance
frequencies. [have designated proton nuclei in order of proximity to
backbone HN nucleus, HA, liB , HC. .. . (Table 7). All of the 7 residues (SP-
BI•7) were assigned, however some of their protons did not produce any
observable correlation peaks in order to be ass igned. For prolines,because
ofthc resonance similarity it was not possible to ass ign theirresonancesto
particular prolines within the sequence. The remaining unassigned peaks
likely originated from peptide impurities. Changes in intensity of peaks
were used to assess the positionofSP-B1.7i n the micelle. 16-doxyl-stearic
acid (l 6-DSA) was added to the peptide/micelle sample, DSA is a
paramagnetic detergent-soluble reagent. The proximity to this reagent leads
to a marked intensity reduction of all NMR signals of nearby protons (Hilty
etaI.2004).
A linewidthbroadening and thus a height reduction of signals were
observed for the entire spectr um. The level of proton intensity reduction
indicates the proximity of proton groups to the center of micelle. The
intensity reduction of peaks was monitore d in TOCSY spectra , and then
peak intensities were used to prepare a plot (Figure 17). Data analysis
showeda substantia ldecreaseinpeak intensitiesanddisappearanceofpeaks
correspond ing to residues I and2 suggestingthcscrcsiduesarc dceply
inserted in the micelle. However unexpectedly severa l peaks showed
increase in intensity.
Table 7. 'H Chemical shifts of the N-tennina l insertion sequence ofSP-B from the
TOCSY experiment on SP-B' _7. HA, lID, ... respectivel y stand for proton nuclei
in order ofproximitytobackboneHNnucieus.
HB
(ppm) (ppm) (ppm)
Not 4.518 2.739 3.084
found
HC
(ppm)
7.292
HD HE HF HG
(ppm ) (ppm) (ppm ) (ppm)
7.672 6.8657.3757.277
3.847 1.7812.122 1.292 1.545
4.382 1.771 2.283 1.941 1.778
4.531 2.038 2.141 1.544 1.160
3.6593.1 76 ---
3.474 3.236
3.788 3.449
Not
found
Not
found
Not 4.397
found
0.994 0.998 1.134 Not found
7 6
8 1H frequency (ppm)
0 0
0
0 "
0 ' ,
4 4
•
8
~ lH frequency (ppm)
Figure 16. (A) 20 TO CSY spectra of 2 mM SP-B 1•7 in 300 mM SOS , at pH 5
and 45°C. The HN-HX corr elation region is point ed out through the panel coming
off the spectra. HX could be any type of proton nuclei except HN. (B) at pH 5 and
45°C after additi on of 0.6 mM 16-0SA. 128 scans were record ed for each
experiment at 80 ms mixin g time.
DSA/NoDSA2D TOCSY cross -peaks intensity ratio
Figure 17. Effect of 0.6 mM 16-0SA on Nvterminal insertion peptide of SP-
B. The ratio of 20 TOCSY cross-peak intensity with and without 16-0 SA is
plotted. X axis represents the amino acid and correspondin g proton groups
of each corre lation peak. HA. HB• ... respective ly stand for proton nuclei in
order of proximit y to backbone HN nucleus. Note that it was not possible to
ass ign the proline resonances to particularprolines within the sequence.
3.9. Characterising the structure oj Super-Mtni-B
Super-Mini-B was chemically synthesized and purified by Alan
Waring Lab at UCLA, USA (Walther et aI., 2010) followin g a similar
procedure to that used for SP-B 1•7 (Section 2.6). None of the residues were
isotope labeled. The peptide is in the oxidized form, containing four
cysteines with a disulfide bond between pairs of cysteines.
CO studies were carried out to assess secondary structural
character istics of Super-Mini-B. CO spectra of I mM Super-Mini-B were
recorded at 25°C and pH 5 in aqueous solution 40% HFIP (plus 50% H20
and 10% 0 20 ), as well as membrane-like environments (90% H20 , 10%
0 20 , 0.2 mM OSS, and 150 mM deuterated SOS). Efforts to solubilize the
peptide in either 40% HFIP or SOS buffer were nearly successful; however
a small portionof the sample was precipitated.Secondarystructuralfeatures
of thc soluble portion were calculated from the CD spectra using COPro
software (http://lamar.colstate.edu/-ss reeram/COPro) and CONT IN/LL
analysis method (Sreerama and Woody, 1993; 2004). In 40% HFIP the
structure content was 21.8% a -hclix, 13% Il-structure and 38.8% random
coi l. In SOS buffer, the a -helical content increased to 24.3%, Il-structure
content did not change while the unordered structures decreased (Il-
structures 13% and unordered structures 35.5%) . The tendency of Super-
Mini-B to form a polyprolin e II helical structure was similar in HFIP and
SOS (- 6%). However, this tendency was severely higher (to 13% for SP-
BI_7) in the absence of the helical portions ofSuper-Mini-B (SP-BI.2s, 6J_78)
(Figure 18 and Table 8). The CO spectra were acquired from a high
concentration (I mM) ofthe peptide because later I need to compare results
of NMR and secondary structural studies . As a result, I used the same
samples for both studies. however dilu ting the samp le when I was repeating
my work (to 0.5mM) did not show any difference in secondary structural
content s with I mM concentra tion (data for 0.5 mM are not represented in
the thesis).
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Figure 18. Far-UV CD spectrum of I mM Super-Mini-B dissolved in 40%
HFIP (plus 50% H20 and 10% 0 20 ) at pH 5 as well as in the presence of
150 mM SOS (90% H20 , 10% 0 20 , 0.2 mM DSS, and 150 mM deuterated
SDS). All spectra were taken using a I mm path-len gth quartz cuvetle from
Table 8. Secondary structural content of I mM Super-Mini-B. in the presence
of 150 mM SOS (plus 90% I-hO and 10% 0 20 ) as well as in 40% HFIP (plus
50% H20 and 10% 0 20 ) at pH 5. Structural content percentages were
calculated from CO spectra data using Woody and co-workers method
(Sreeramaand Woody I993 ;2 000;2 004).
Seco ndary a-lleli' 3/10 {I-Sheet Turn Polyprolinell nordered
Stru ctur e (%)
Super-Mmt-B 24.3 6.7 13.0 14.4 6.1 35.5
in SDS
Super-Mini-B 21.8 6.2 13.0 14.2 6.0 38.8
inllFII'
Secondary structural content of Mini-B were calculated and
compared to Super-Mini-B. The a- helix content was significantly greater in
Mini-B compared to Super-Mini-B. Moreover Mini-B possesses lower
values for fl- and unordered structures than Super-Mini-B (Figure 19). A
small value is calculated for polyprolineh elix II structures in Mini-B, while
the peptide does not have the N-terminal insertion sequence that forms
polyproline helix II (PPIl). This PPII helix content is negligible and is
calculated because of using basis set 2 from COPro software (Johnson,
1999).
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Figure 19. Far- UV CO spectrum of 1.5 and 1 mM Mini-B diss olved in 90%
H20, 10% 0 20, 0.2 mM OSS, and 150 mM deuterated SOS . Both spectra
were taken using a 1 mm path-length quartz cuvette from 190 nm to 260 nm
at 25°C. Table: corresponding percentages of secondary structural cont ent
of I mM Mini-B in the presenc e of 150 mM SOS . Structural cont ents were
ca lculated from CO spectra data using Wood y and co-worker s method
(Sreera ma and Woody 1993; 2000 ; 2004 ).
3. /0. So lution nu clear magn etic resonance spect roscopy (NM R) structura l
characterization of S uper-M ini-B
Super-Mini-B . I mM of the peptide was dissolved in HFIP buffer (40%
HFIP plus 50% H20 and 10% D20 , 0.2 mM DSS) as well as in the presence
of ISO mM SOS (90% H20 , 10% 0 20 , 0.2 mM OSS, and ISO mM
deuterated SDS). Results of 10 I H NMR experiment s in HFIP and SDS
were similar in terms of the spread of NMR signals (dispersion) over 6.8-7.8
ppm. The dispersion was poor in both solvents indicating that the peptide is
In order to find the conditions corresponding to the best prote in
signal, the solvent, temperature and pH were varied . First the 10 I H NMR
experiments were carried out on different concentrations ofSuper-Mini-Bin
40%HFIPbut1er . The peptide was titrated into the buffer to deterrnine the
peptide concentration corresponding to the best protein signal, and to look
forevidenceofpeptide-peptideinteractions anddimerizationin the soluble
part of the sample. No changes were observed in the appearance of the
spectra (i.e. relative peak intensities, chemica l shills, etc.) with different
peptide concentration s (Figure 20).
Figure 20. A) ' H NMR spectra of Super-Mini-B were dissolved at three
concentrat ions (blue OJ mM, green 0.6 mM, red 0.9 mM) at pH 5 and 25°C
in a so lution of 40% HFIP butTer (plus 50% H20 , 10% 0 20 , 0.2 mM OSS)
32 scans were used, spectra were processed using iNMR
(http:// .inrnr.net). Note that the intensity was normalized using the
height of the OSS peak (peak at 0 ppm frequency).
Figure 20. B) HN region of IH NMR spectra of Super-Mini-B dissolved at
three concentra tions (blue OJ mM, green 0.6 mM, red 0.9 mM) at pH 5 and
25 °C in 40% HFlP (plus 50% H20 , 10% 0 20, 0.2 mM OSS).
In order to determine the temperature corresponding to the best
protein signal, ID IH NMR experiments were acquired at different
temperatures on I mM peptide sample. In 40% HFIP buff er the best signal
intensity was acquired at 40°C. At higher temperatur es the peptide looks
more structured than at low temperatures, as evidenced bythe greaterpeak
dispersion in the HN region (Figure 2 1). Similar results were obtained from
ImM Super-Mini-B in SDS micelle containing buffer; by increasing the
tempera ture the peak dispersion in the HN region (-7-9 ppm) increased. The
greatest intensity was recorded at 45°C (Figure 22). Thus the temperatures
which the peptide had optimum signal intensity in HFIP and SDS buffer
were over laid for comparison (Figure 23). The appearance of the HN region
(i.e. peak intensities and chemical shifts) for the SDS sample looks more
structured than the HFIP spectra (Figure 23B) . As a result this condition, I
mM Super-Mini-B dissolved in a solution of90% H20 , 10% D20 , 0.2 mM
DSS, and 150 mM deuterated SDS at pH 5 and 45°C, was selected for
running the 2D NMR spectra.
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Figure 21. A) 'H NMR spectra of 0.9 mM Super-Mini-B in 40% HFIP
buffer at pH 5 and varying temperatures (red 5°C, green 15°C, black 25°C
and blue 40°C) recorded with 32 scans. Spectra were processed using
iNMR (http://www .inmr.net).
Figure 21. B) HN region of I H NMR spectra of 0.9 mM Super-Mini-B in
40% HFIP buffer at pH 5 and varying temperatures (red 5°C, green 15°C,
black 25°C and blue 40°C).
Figure 22. A) I H NMR spectra of I mM Super-Mini- B at pH 5, dissolved in
a solution of 90% H20 , 10% 0 20 , 0.2 mM OSS, and 150 mM deuterated
SOS at 25°C (green), 35°C (blue) and 45°C (green). For 10 I H NMR, 32
scans were used; spectra were processed using iNMR
(http ://www .inmr.net).
Figure 22. B) HN region of I H NMR spectra of I mM Super-Mini-B
dissolved at pH 5 in a solution of 90% H20 , 10% 0 20 , 0.2 mM OSS, and
150 mM deuterated SOS at 25°C (green) ,35 °C (blue) and 45°C (green).
Figure 23. A) IH NMR spectra of I mM Super-Mini-B in 150 mM SOS
buffer at pH 5, 45°C (red) and in 40% HFIP, pH 5, 40°C (blue). For 10 I H
NMR,32scanswere used.
Figure 23. B) HN region of 'H NMR spectra of 1 mM Super-Mini-B in 150
mM SDS buffer at pH 5, 45°C (red) and in 40% HFIP, pH 5, 40°C (blue).
An important goal of structural studies of Super-Mini-B is to
characterize its structure and function under physiologicaly relevant
conditions. In this study the physiological condition was approximatedbya
buffer with SDS micelles at pH 7 and 37°C temperature. 10 and 2D NMR
experiments on I mM Super-Mini-B in SDS micelles were acquired at pH 7
and 37°C and the results were compared to the spectra from acquisition of
the sample at pH 5 and 45°C. Peaks intensity was significan tly greatera t pH
5 and 45°C than at pH 7 and 37°C (Figure 24). Overlaid 10 spectra of
Super-Mini-B and Mini-B shows a similarity in dispersion over the li N
region suggesting a similar level of structuring for both peptides (Figure
25). However a decrease in peak intensity and broadenin g for Super-Mini -B
suggests an increase in size of the particles (Mini-B results; Courtesy of
MuzaddidSarker).
Figure 24. A) IH NMR spectra of I mM Super-Mini-B in SOS butTer(90%
H20 , 10% 0 20, 0.2 mM OSS, and 150 mM deuterated SOS) at pH 5, 45°C
(red)andpH 7, 37"C (green).
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Figure 24. B) HN region of I H NMR spectra of 1 mM Super-Mini-U in SDS
buffer (90% H20 , 10% D20 , 0.2 mM DSS, and 150 mM deuterated SDS) at
pH 5, 45°C (red) and pH 7, 37°C(green).
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Figure 25. A) lH NMR spectra of 1.5 mM Mini-B at pH 7 and 37°C (blue),
1 mM Super-Mini -B at pH 7 and 37°C (green) and at pH 5 and 45°C (red).
Spectra were recorded with 32 scans. Results show more intense peaks in
the HN region for Mini-B compared to Super-Mini-B.
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Figure 25. B) HN region of 'H NMR spectra for 1.5 mM Mini-B at pH 7
and 37°C (blue), 1 mM Super-Mini-B at pH 7 and 37°C (green) and at pH 5
and 45°C (red)
After using the lO s to optimize the sample conditions, 20 NMR
experiments were next carried out to detcrmine the structural fcaturcsof the
peptide. The NOESY experiment on Super-Mini-B in SOS buffer at pH 7
and 3rC had a very small number of broad cross peaks. This may be due to
aggrega tion and a consequent increase in tumblin g time under these
conditions (Figure 26). In spite of the lower number of peaks observed at
pH 7 and 37°C compared to pH 5 and 45°C (Figure 27), over laying their 20
NOESY spectra did not show any significa nt changes in chemica l shift
(Figure 28). The absence of changes in chemical shift indicatest hat the local
structure is likely similar in the two conditions , however, the changes in
peak shapc arc consistent withdifferencesin overall complex size.
Figure 26. Solution NMR 20 NOESY spectrum of 1 mM Super-Mini-B
dissolved in a solution of 90% H20, 10% 0 20, 0.2 mM OSS, and 150 mM
deuterated SOS at pH 7 and 37°C. For the 20 NOESY, 128 scans were
used with a mixing time of2 00 ms.
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Figure 27. Solution NMR 20 NOESY spectrum of 1 mM Super-Mini-B
dissolved in a solution of 90% H20 , 10% 0 20 , 0.2 mM DSS, and 150 mM
deuterated SOS at pH 5 and 45°C. For the 20 NOESY, 128 scans were
used with a mixing time of200 ms.
Figure 28. A) Overly of2 D NOESY spectra of 1 mM Super-Mini-B in 150
mM SDS solution at pH 7 and 37°C (red) and pH 5, 45°C (blue) under same
acquisitio n parameters; 128 scans were used with a mixing time of2 00 ms.
fll
Figure 28. B) Overly of HN-HX correlation region from 20 NOES Y spectra
of 1 mM Super-Mini-B in 150 mM SOS solution at pH 7 and 37°C (red) and
pH 5,4 5°C (blue).
The Overlaid 2D NOESY spectra of Super-M ini-B with Mini-B
shows the positions of Mini-B' s peaks did not appear to change greatly in
the context of Super-Mini-B. However Super-Mini-B's peaks are broader
and some of the weaker peaks apparent in the Mini-B spectrum are abse nt
from the Super-Mini-B spectrum. The broadening and weakening of the
intensity in Super-Mini-B compared to Mini-B is consiste nt with a
substantially slower tumbling time for Super-Mini-B, that is likely related to
an increase in aggregatio n (Figure 29).
The overall results of 2D NOESY experiments in Mini-B and
Super-Mini-B indicate that the additiona l 7 residues do not induce any
majo r changes in the structure of the helical regions of the peptide.
Howeve r, there are small changes in peak positions that are to be expec ted
based on the differenees in temperature (Figure 29B).
Figure 29. A) Overly of 2D NOESY spectra of I mM Super-Mini-13 in 150
mM SDS solution at pH 5 and 45°C (red) and 1.5 mM Mini-B in 150 mM
SDS pH 5 and 37°C (blue) under similar acquisition parameters; 128 scans
were used with a mixing time of 200 ms.
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Figure 29. B) Overly of HN-HX correlation region from 20 NOESY spectra
of I mM Super-Mini-B in SDS solution at pH 5 and 45°C (red) and 1.5 mM
Mini-B at pH 5 and 37°C (blue).
The position of the N-terminal insertion sequence of SP-B (SP-B 1_
7) in the micelle, as a fragment in the context ofS uper-Mini-B, was assessed
by addition of DSA to the peptide/micelle sample. A procedure that is
similar to what mentioned before for the DSA TOCS Y on SP-BI_7(section
3.8) was carried out to analyze changes in Super-Mini-B peaks. The N-
terminal insertion sequence peaks in the TOCSY spectrum ofSuper-Mini-B
were assigned (Table 9). The number of observable peaks for the N-tenni nal
7 residues in Super-Mini-B was less than SP-BI _7, however, protons
associated with the N-tenn inal residues retained chemica l shifts similar to
protons at the same spin systems in SP-BI_7. Peaks intensity reducti on in
presence of DSA was monitored for the N-terminal 7 residue assoc iated
peaks. A decrease in intensities was detected for some peaks. The
disappearance of peaks corresponding to residues 1 and2 indicatesthe
peptide is deeply inserted in the micelle (Figure 30).
Table 9. I H Chemical shifts of the N-tenni nal insert ion sequence of SP-B from the
TOCSY experiment on Super-Mini-B . HA, HB, ... respectivel y stand for proton
nucleiin order ofpro ximityt obackboneHNnucleus.
HA HB HC
(ppm) (ppm) (ppm) (ppm)
Not Not Not found 7.317
found found
Not 2.284 2.194 1.595 1.595
found 2.257 2.306 1.340 1.167
Not
found
Not
found
Not Not
found found
HE HF HG
(ppm) (ppm) (ppm)
6.906 7.3757.324
Not Not Not
found found found
OSA/NO OSA 20 TOCSY cross-peak intensity ratio
-~-I'-tl:_ 11- -
Figure 30. Effect of 0.6 mM 16-0S A on N-terminal residues of I mM
Super-Mini-B in 150 mM SOS, pll 5 and 45°C. The ratio of 20 TOCSY
cross-peak intensity with and without 16-0S A is plotted along the amin o
acid sequence and corresponding proton groups. The analysis process was
described in section 3.8. Note that it was not possible to assign the proline
resonances to particular prolines within the sequence.
DOSY experiments provide a measure of the size of particles, such
as micelles or protein-micelle complexes by determining the diffusion
coeffic ients. DOSY results can be affected by protein-l ipid and protein-
protein interactions since the size would change upon binding(Price, 1997).
In order to assess the size of particles, the diffusion coefficie nts 0 fS uper-
Mini-B in SDS micelles were determined from the DOSY experiment at
30°C. The spectra were processed using iNMR and the diffusion constants
calculated using the "DOSY" package in DOSYTooIBox08 (Nilsson, 2009).
The correspond ing hydrodynamic diameter calculated using the Stokes-
Einstein equation for spherical particles undergoing freediffusion in
solution,
D =k BT/3rrll dll
, that kB is the Boltzmann constant, T is the absolute temperature, 11is the
viscosity of the solution and d ll is the hydrodynamic diameter of the
particle. The hydrodynamic diameter corresponds to the diameter of a
sphere that would be diffusing at the same rate. The apparent hydrodynamic
diamete r fo r I mM Super-Mini-B was 7.06 nm at pH 7, 30°C while for 1.5
mM Mini-B was 7.02 nm at pH 7, 37°C (Sarker, PhD Thesis, Booth lab)
(Figure 31).
Che~ical shiftIppm2
Figure 31. 20 OOSY spectrum of 1 mM Super-Min i-B in SOS at 30oe.
The conventional 20 OOSY spectra show approx imate measures of the
translational diffusion coefficie nts of various species present in the sample
(along Y axis) with respect to their 1H chemica l shifts (X axis).
3. // . Solid-state Ill/clear magnetic resonance (NMR) characterization of
lipid-protein interactions of Super-Mini-B
Solid-state NMR experim ents were used to assess interaction s of
Super-Mini -B with membranes . In this study, solid-state NMR experiment s
were perform ed with lipid bilayers mechanica lly oriented on a solid
substrate. The inclusion of the peptide into the samp les can lead to
disruption s in the overall orientation of the bilayers, as well as changes in
acyl chain order. These changes reveal aspects of Super-Mini-B/lipid
2H solid state NMR experiment s were performed with Super-Mini-B
in oriented lipid bilayers composed of POPC-d31:POPG (7:3, w/w) . In the
absence of the peptide , deuterium peaks are well resolved with the widest
splittings at ±27.08 kHz showing that the lipid bilayers are well aligned . The
NMR spectrum after addition of the peptide (1 mol %) shows changes. The
signal intensity on the shoulders and the splitting significantly decreased,
and the spectra become superpositions of more than one compon enl. One
compon ent exhibit s larger splittings, correspondin g to bilayersorientedwith
bilayer normal paralle l to the magnetic field and the second component
displays features with splittings that are half of the oriented component
splittings. The second component is most likely due to randomly oriented
bilayers(see the arrows in Figure 32). Thus ,thepresenceofSuper-Mini-B
causesa smallfraction ofthebi layerst o losetheirorientation(Figure 32).
By increasing the temperature the splitting did not change. but
more signals at half the width of the oriented spectrum were observed. This
observation indicates a greater level of bilayer perturbation at higher
temperatures (Figure 33).
Frequency (kHz)
Figure 32. lH spectra of mechanically oriented POPC-d31:POPG 7:3 with (upper
panel) and without (lower panel) I mol % Super-Mini-B. The spectra were
acquired with 60000 scans at 23°C. The dashed line arrow," -->"' indicates
oriented and the black arrow"-7" indica tes randomly orientated species.
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Figure 33. 2H NMR spectra of mechanica lly oriented bilaye rs compo sed of
POPC-dJ1:POPG (7:3, w/w) in the presence ofSuper-Mini-B ( I mol %) at
The order parameter profile approach indicate s the effect of the
peptide on the orien ted fraction of the lipid bilayerbymeasuringtheeffect
of the peptide on chain order at different positions along the chain. The
Sternin , et al. method (Sternin et aI., 1988) was used to extract orde r
parameter profiles from 211NMR spec tra of POP C-dJI:POPG (7:3, w/w) in
the absence and presence of the Super-Mini-B and Mini-B (I mol %).
Analyzed data showed a greater disru ption of lipids chain order inpresence
of Super-Mini-B than Mini-B (Figure 34). However the orde r para mete r
proti les will not be abso lute ly acc urate. To calculate the orde r parameters
fo r the regions of the spectrum whe re the peaks are not well resolved , the
total areaunder the curvei su sed to rth e calculation. Since this area includes
the area under signa ls from both the orie nted and unoriented peaks, this will
not be entirely accurate for spec tra that cont ain a substan tial unoriented
port ion (Mini-B resu lts and calculations ; Courtesy of Dharamaraj u
Palleboina, Booth lab).
The echo decay time measurement ex periment gives some
information about the rates of lipid motions. Adding a pept ide tends to
increase the echo decay rate and shorten the echo decay time. This indicates
that the peptide affec ts the dynamics of the bilayer lipids. The echo decay
lime for POPC-dJI:POPG sample was 1.019 ms in the absence of the
peptide and 0.564 ms in the prese nce of Super-Mini-B. Thus, the presence
of the peptide causes a large increase in lipid motions (Figure 35).
A)
Figure 34. Order parameter profiles of POPC-dJ1:POPG with and without
Super-Mi ni-B (a), Mini-B (b). (c) Shows the data from (a) and (b) overlaid.
Data points extrapolated from 2H NMR experiments on POPC-dJ1:POPG
(7:3, w/w) in the absence and presence of the peptides (I mol %). 5MB and
MB stand for the lipid-only samples prepared to compare with Super-Mini-
B and Mini-B containing samples respectively. Samples were prepared with
the same lipid composition and preparation condition. The slight difference
in order parameter of lipid only-samples is due to the expected differences
in similar samples with different preparation time. Parameters for Super-
Mini-B extracted with help from Dharamaraju Palleboina, Booth lab.
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Figure 35. Echo Decay value for POPC-d31:POPG (7:3, w/w) in the absence
(A) and presence (B) of I mol % Super-Mini-B at 35°C. Echo decay time is
calculated based on the slope. Results were extracted with help from
DharamarajuPalieboina , Booth lab.
To understand the exac t mechanism of SP-B ' s function, we need
to know the structure of the protein. The extraction and purification ofSP-B
from natural sources have been accomplished (Baatzet al.,2001), however,
studiesto define thestructureof SP-B have not been successf ul yet. Isotope
labeling of amino acids is one of the techn iques employed to obtain more
information on protein structure in NMRstudies. Fora protein the size of
SP-B, isotope labelling is essential to obtain an atomic resolution structure.
In order to label amino acids, the protein needs to be produced
recombinantly or,inthec ase of shortpeptides, synthesizedchemically.
The hydrophobic nature of proteins like SP-B poses many
ditlicultie s in recombinant expression (Kiefer, 2003). As a result these
proteins are often produced in heterologous systems as fusions with soluble
proteins. Due to SP-B's hydrophobicity, as well as lytic and fusoge nic
propert ies (Ueno et al., 2004), in this study SP-B was fused to SN
(staphylococcus nuclease). A plasmid containing the full encoding sequence
ofSP-B was expressed in C43 straino fE. coli .
DNA sequencing analysis of the cloned construct confirmed the
expected sequence of the SN-SP-B encoding gene. Attempts to detect the
full sequence of the expressed protein were only partially successf ul. SDS-
PAGE has been reported promising for most likely all proteins (including
hydrophobic ones). Since I know that my desired protein is highly
hydrophob ic, I tried Urea-SDS-PAGE as well by adding up 8 M urea to all
of the SDS-PAGE buffers (load ing, runn ing and ge l preparin g buffers. Data
are not shown since the pictur es of the gel does not have the publ ishable
quality but results were pretty similar to the regular SDS-PAGE . I have
repeated expressio n and SDS-PAGE for severa l times and got similar
resultsThe apparent size of the purified expressed SN-S P-B on SDS gel was
lessthanthe expectedmolecul armass, althoughWestemblottin g contirm ed
presence of the histidine tag in the expresse d peptide. This observation may
result from the fact that hydroph obic proteins travel through the ge I but their
dynamics is altered because of thei r hydrop hobic surfaces , resulting to run at
different positions than the expec ted molecular weig ht (Clark and
Pazdem ik, 2008).
The chance of activation of proteases at the ce ll disrupti on steps is
almost zero EDTA and PMSF were used as protease inhibitors EDTA binds
the metal ions that the metalloproteases need to function.The half-life o f
PMSF is 110 min at pH 7 and 55 min at pH 7.5, all at 25°C. Durin g cell
rupture sampleswere kept onice and for the next steps alt er cellrupturetill
the end of' purifi cation, all of the procedure was acco mplished in a co ld
Severa l param eters were assessed to probe other possibiliti es for
the apparently low molecular weight of SP-B on the gel. The possibil ity of
translation interrupti on or proteolysis at induction step was investigated; this
could happen due to the lack of nutrients (Reeve et a!., 1984 ; Groat et al.,
1986). The possibility of breakage at the cell disrupt ion steps was also
assessed. No evidence of any of these possibilities was detected ; the
apparent size of the expressed SN-SP-B pept ide did not change under any
Identi fication of the amino acid sequence of the expressed protein
by mass spectrosco py was limited to a fragment of the fusion protein and
the N-terminal fragment of SP-B. The analysis of hydrophobic proteins is a
challenge to mass analysis (Lubec and Aljchi-Sadat, 2007; Cech and Enke,
2000). In addition to hydrophobic ity, despite reducin g the proteinpriorto
mass spectrosco py, it is still possible that some disulfide bonds remain
which could limit the ionization. Since no changes were detected in the
expressed protein under varying conditions, future works can be focused on
overcoming limitations in detecting this highly hydrophobic peptide.
Nd-SP-B (N-terminal deleted SP-B) is a novel near full-length SP-
B peptide that was produced by deletion mutation at the N-terminal end of
SP-B, SP-B1•7 was removed from the peptide. The size of the expressed
peptide on the gel was less than the expected molecular weight and ion
search analysis could only identi fy fragments of SN. Again the high
hydrophobicity of the peptide limited the sequence identification. However
the structural studies on this near full-length pept ide would give valuable
informationo ns tructureandfunctionofSP-B.
Even if the sequence of the expressed SP-B cannot be confirmed by
other methods, if conditions can be found which allow for high resolution
NMR data. it will be apparent from this NMR data if the expressed protein
has the expected sequence or not. In order to confirm the sequence of
constructs in the sample. the subjects that should be studied in futureworks
regarding to expression and purification of SP-B and Nd-SP-B are
expression of the protein in minimum media for isotope labellin g of the
selected amino acids and using the organic extraction method to purify the
expressed protein inlaterpurilication stcps atlercleavage from the fusion
part or to purify it from remained impurities.
While working on the full-length SP-B pose many difficult ies,
fragments containing individual helices or pairs of helices ofSP-B were
shown to retain biological activ ities of the full-length protein (Revak et al.,
1991: Veldhuizen et al., 2000: Waltheretal., 2002) . Super-Mini-B retained
higher values for surfactant activities (e.g. arteria l oxyge nation and dynamic
compliance) than full-length SP-B and Mini-B (Walther et al., 20 10). Since
Super-Mini-B and Mini-B have the same amino acid sequence except for
the presence of the N-terminal insertion sequence (SP-BI_7) in Super-Mini-
B, Walther' s study (Walther et al., 2010) showed the importance of SP-B I _7
in surfactant activit y of SP-B for the first time.
The N-tenn inal insertion sequence of SP-B (SP-B'_7) is a short
peptide consisting of 7 amino acids. SP-B I _7 retains polyprolin e helix
structure (Table 6) and resemble s a group of cell penetrating peptide s
(CPPs) (Pujals and Giralt, 2008). In this group ofCPPs, the polyproline
helix works as a scaffold to keep hydrophobic and cationic groups close
together that promote membran e penetration and destabilization respectively
(Ragin and Chmielewski 2004 ; Shai, 1999). A similar order of amin o acids;
hydrophobic residues, polyproline helix and cationic residues, are set at the
N-tenn inal fragment of SP-B (SP-B I_24) . This similarity of (SP-B I_24) with
CPPs may explain the lytic and fusogenic propertie s of N-tenn inal based
SP-B peptides (Ryan et al., 2005) and also can be considered in models to
explain mechani sm offunction ofS P-B.
Structural studies on SP-B I _7 alone and in the context of Super-
Mini-B helped to define its structure and function within the context of
Super-Mini-B. The depth of insertion in SDS micelle was calculated based
on DSA-TOCSY experiment. Similar results were acquired for SP-BI _7
fragments of Super-Mini-B and SP-B I •7individually; the N-terminal peptide
is located superficially in the micelle and may anchor SP-B to the lipid
bilayer (Figures 17 and 30). However in this study, results of DSA
experim ents were brought into question by the unexpected increase in
intensity of some peaks after addition of DSA. The increase in intensity can
be due to a contamination or induced changes in the micelle by DSA
(Mravljak et al., 2006). Use of another paramagnetic substance such as
manganese is an alternative way to confirm or refute the DSA results of this
study (Gaye n et al., 20 11). Other approaches sueh as tryptophan
fluorescence spectrosco py can also give information on insertion 0 f Super-
Mini-B in the micelle (McKnight et al., 1991).
In order to assess structural features induced by the presence 0 fS P-
131•7, structural studies on Mini-B (Sarker, et al., 2007) were compared to
studies on Super-Mini-B. Although similar conditions were used for the
acquisition of the NMR data, the spectra of Mini-B and Super-Mini-B
demonstrated considerab le differences. The positions of the 2D NOESY
peaks of Mini-B did not appear to change greatly in the context ofSuper-
Mini-B, however the Super-Mini-B peaks are broader and some of the
weaker peaks apparent in the Mini-B spectrum are absent from the Super-
Mini-B spectrum. The overall results ofNOE SY experiments in Mini-B and
Super-Mini-B indicate that the additional 7 residues do not induce any
major changesinthe structure ofth eh elicalregions ofthepeptide , however
the broadening and disappearance of peaks suggests formation of large
particles in Super-Mini-B.
The size of particles for Super-Mini-B and Mini-B was determin ed
based on diffusion coe tlic ient values in DOSY experiments.
hydrodynamic diameter for Super-Min i-B particles was greater than Mini-B.
The broadness and low number of peaks in Super-Mini-B can be evidences
for formation of large size particles and resulting slow tumblin g.
Unfortunately it was not possible to obtain high quality DOSY data under
the same experimental conditi ons as were used for the 2D NOESY and
TOCSY spectra. Likely due to turbulence in the sample, it was only possible
to acquire reliable DOSY spectra at lower temperatures, i.e. 30°C. At this
temperature, the measured translational diffusion is similar to that measured
for Mini-B at a higher temperature (I mM Super-Mini-B at pH 7, 30°C was
7.06 nm and 1.5 mM Mini-B at pH 7, 37°C was 7.02 nm) which is puzzling
considering the much broader linewidth observed in the NOESY and
TOCSY for Super-Mini-B compared to Mini-B . However, this controversy
may be due to the fact that rotational diffu sion (which is reflected in
linewidth) is more sensitive to the complex size than translationa l diff usion
(measured by DOSY), as well as the fact that the protein/micelle complexes
may change shape substantially by changes in the temperature. Other
approaches to measure size and shape of part icles are dynamic light
scattering (DLS) (Ghosh, 2005) and small angle neut ron scattering (SANS)
(Egelhaafet al.,2003) that can be used to provide additional informationo n
the size of Super-Mini-B,
Further studies by circular dichroism gave us a better view of the
structure of the peptides. The presence ofN -terminal insertion sequence of
SP-B induced greater contents of B- and unordered structures and also less
a -helica l structures in Super-Mini-B than Mini-B . This observation can be
considered as a transition from a-h elices to unordered and later B-structure s.
Proteins rich in B-structuresare prone to agg regate and produ ce largesize
particl es (Ch itiet al. , 2003).
Further studies by solid-state NMR assessed lipid bilayer
perturbation propert ies of Super-Min i-B and Mini-B. The lipid inte ractiv e
property of the N-tenn inal helix of SP-B (Mini-B and Super-Mini-B as
well ) has been reported before, the tryptoph an residue has the key role of
this property (Sarker ct aI., 20 11). Result s of the current study show the
additional SP-B 1•7 provid es Super-Mini-B a greater level and probabl y a
tryptophan-independ ent mechanism of lipid interaction . This level of lipid
layer perturbat ion by Super-Mini-B confirmed the ass umption that SP-B I _7
does not work onl y as an anchor but also it has a critical role in SP-B ' s
interference with surfactant lipid layers (Figure 34) . SP-B I _7 can be crucial
for mediating transfer of lipids by SP-B at extension and compress ion
phases of respiration.
The effect of SP-B I _7 on SP-B's surfactant activity was
underestim ated until a study showed this short peptide could provide
significa nt changes in surfactant activ ities (Waltheret aI., 20 10). Structura l
intlu ences of SP-B I_7were also unexpected . Molecular dynamic s simulation
sugges ted that SP-B, _7pro vides a surface for homodimeriza tion (Walther et
al., 2010) . NMR studies in this research did not show any evidences for
dimerization (Figure 20). Instead of dimerization, large size particles and jl-
structures were detected (Figure 29 and Table 8).
One of the goals of this research was to learn more about the
structure of the full-length SP-B by studying the structures of its fragments.
The structure of Super-Mini-B was composed of helical regions of Mini-B
in a smaller portion and a larger portion of p-and unordered structuresthan
Mini-B . [ suggest that the extended polyproline helix exposes the
hydrophobic residues of SP-B 1•7 to interact and form unordered and cross-]l
structures with hydrophobic helical regions of Super-Mini-B. Circular
dichroism of Super-Mini-B in a membrane-like environment such as
liposomes can provide extra evidence that the p- and unordered structures
may provide the essential property of Super-Mini-B and SP-B for
lipid/memb rane interactions .
SP-B is the only essential protein component ofl ung surfactant (Clark
et al., 1995; Tokieda et al., 1997). The current research will provide some
basis for production, structure and understanding the mechanism of function
ofSP-B. Knowledge of the molecular mechani sm ofSP -B can improve the
current aspects in surfactant replacement therap y and sugges t new
perspectives lor ARDS treatment as well.
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Supplementa l mat eri als
Supplementary figure 1.
Figure S I. SDS-PAGE gel, Comass ie stained of purified SN-SP-B . While
we were expecting only onc band (- 27 kDa for SN-S P-B), three bands were
detected in the purified sample afte r column chromato graphy




